<p>Annualized rate of adverse events per patient-year by dialysate type.</p>

NIAID Data Ecosystem2026-05-10 收录

数据链接：

https://figshare.com/articles/dataset/_p_Annualized_rate_of_adverse_events_per_patient-year_by_dialysate_type_p_/32000306 数据链接链接失效反馈

官方服务：

资源简介：

Annualized rate of adverse events per patient-year by dialysate type.

创建时间：

2026-04-13

粤北第二人民医院近三年不良事件明细数据集

不良事件分析

患者安全风险管理

本数据集源自粤北第二人民医院不良事件管理记录数据，涵盖了患者事件发生详情、后续处理措施等多维度信息。该数据集包含了 274 条不良事件信息记录，涉及涵盖性别、发生时间、发生时病人活动状态等多方面内容。数据经标准化整理后形成结构化数据集，可用于医疗安全风险评估、不良事件归因分析、护理质量改进等场景。

广东省数据知识产权存证登记平台2026-01-08 更新160

A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system

用药安全

不良事件分析

Ospemifene has been authorized for the treatment of vulvovaginal atrophy (VVA). This study wasto evaluate adverse events (AEs) associated with ospemifene by data mining the US Food and Drug Administra

DataCite Commons2024-02-27 更新130

Additional file 4 of Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients

肿瘤治疗安全性

不良事件分析

Additional file 4. Adverse Events.

DataCite Commons2024-02-08 更新80

Grade 3 or 4 clinical events or laboratory abnormalities.

临床试验安全监测

不良事件分析

Grade 3 or 4 clinical events or laboratory abnormalities.

NIAID Data Ecosystem150

Adverse events in patients taking macrolide antibiotics versus placebo for any indication: Supplementary data set B

用药安全

不良事件分析

Supplementary data B Any reported adverse event that occurred in less than 5% of any group – grouped under the primary System Organ Class, according to the MedDRA coding system.

Research Data Australia80

<p>Annualized rate of adverse events per patient-year by dialysate type.</p>

资源简介：

相关数据集